End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.77 CNY | -0.04% | -0.74% | -9.03% |
Apr. 18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Apr. 17 | Fosun Pharma Unit’s New Drug Application for CMV, HSV Drug Accepted by Chinese Regulator | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.03% | 7.48B | |
+25.31% | 672B | |
+23.31% | 550B | |
-6.45% | 351B | |
+14.65% | 317B | |
+6.76% | 292B | |
+3.06% | 211B | |
+0.40% | 203B | |
-10.99% | 144B | |
-7.90% | 141B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma, Three Others Form Investment Partnership